Skip to main content
HR 2639 118th Congress House Health

Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023

Introduced: April 17, 2023 Introduced by: Sessions, Pete Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Apr 17, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 17, 2023
Introduced in House
 Plain-English summary Congressional Research Service

Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023

This bill requires, as a condition for Medicare payment, specified electrodiagnostic services to be furnished by qualified facilities that comply with accreditation, training, and other quality control requirements, as established under the bill.

Specifically, the bill requires nerve conduction studies and needle electromyography tests to be furnished by facilities that are accredited by an organization that is approved by the Centers for Medicare & Medicaid Services (CMS). The accrediting organization must certify that the facility meets certain standards, including having a quality control program and requiring those who administer needle electromyography tests to have at least three months of specialized training.

The bill also establishes an advisory committee to support the CMS in developing appropriate facility standards.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3
 Cosponsors 2
All 2 Republican 2